Heterogeneous reno-protective effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoietin-stimulating agents in kidney dysfunction: a target trial emulation with causal forest using real-world data

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 

 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

  Back
E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/770fc3fd8c5af8f6dd3e9e825953110c.pdf
Heterogeneous reno-protective effects of hypoxia-inducible factor prolyl hydroxylase inhibitors versus erythropoietin-stimulating agents in kidney dysfunction: a target trial emulation with causal forest using real-world data

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Akira
Okada
Akira Okada aokada@m.u-tokyo.ac.jp The University of Tokyo Department of Prevention of Diabetes and Lifestyle-Related Diseases Tokyo Japan *
Yoshihisa Miyamoto ymiyamoto7070@g.ecc.u-tokyo.ac.jp The University of Tokyo Department of Real-World Evidence Tokyo Japan -
Reiko Inoue inoue.reiko@mail.u-tokyo.ac.jp The University of Tokyo Department of Prevention of Diabetes and Lifestyle-Related Diseases Tokyo Japan -
Kayo Ikeda Kurakawa ikekayo1212@gmail.com The University of Tokyo Department of Prevention of Diabetes and Lifestyle-Related Diseases Tokyo Japan -
Toshimasa Yamauchi tyamau@m.u-tokyo.ac.jp The University of Tokyo Department of Diabetes and Metabolic Diseases Tokyo Japan -
Takashi Kadowaki t-kadowaki@toranomon.kkr.or.jp Toranomon Hospital Department of Administration Tokyo Japan -
Satoko Yamaguchi syamaguc@m.u-tokyo.ac.jp The University of Tokyo Department of Diabetes and Metabolic Diseases Tokyo Japan -
Masaomi Nangaku mnangaku@m.u-tokyo.ac.jp The University of Tokyo Division of Nephrology and Endocrinology Tokyo Japan -
-
-
-
-
-
-
-